{"id":15396,"date":"2022-02-24T02:08:44","date_gmt":"2022-02-24T07:08:44","guid":{"rendered":"https:\/\/www.edentalpracticefinancing.com\/blog\/dental-practice-term-loans-call-904-551-6090-health-systems-weigh-covid-19-vaccine-mandates-for-employees\/"},"modified":"2022-02-24T02:08:44","modified_gmt":"2022-02-24T07:08:44","slug":"dental-practice-term-loans-call-904-551-6090-health-systems-weigh-covid-19-vaccine-mandates-for-employees","status":"publish","type":"post","link":"https:\/\/www.edentalpracticefinancing.com\/blog\/dental-practice-term-loans-call-904-551-6090-health-systems-weigh-covid-19-vaccine-mandates-for-employees\/","title":{"rendered":"Dental Practice Term Loans &#8211; Call 904-551-6090:  Health systems weigh Covid-19 vaccine mandates for employees"},"content":{"rendered":"<p><a href='' target='_blank' rel=\"noopener\">  <\/a><iframe loading=\"lazy\" width=\"580\" height=\"385\" src=\"https:\/\/www.youtube.com\/embed\/2i3unvJEKWk\" frameborder=\"0\" allowfullscreen><\/iframe><br \/>\n<br \/>Meg Tirrell joins &#8216;The News with Shepard Smith&#8217; to report how employers are making vaccines mandatory for employees. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:\/\/cnb.cx\/2NGeIvi <\/p>\n<p>Pfizer and BioNTech have already started their application process for full U.S. approval of their Covid-19 vaccine. Rival Moderna is expected to submit for the same process for its shot later this month.<\/p>\n<p>The mRNA vaccines are currently on the U.S. market under Emergency Use Authorizations, which were granted by the Food and Drug Administration in December. Since then, more than 263 million shots have been administered, according to data compiled by the Centers for Disease Control and Prevention.<\/p>\n<p>Standard vaccine reviews generally take several months to a year or more to determine whether it is safe and effective for use in the general public. But due to the pandemic, which has killed nearly 600,000 Americans, the FDA permitted the use of the shots under an EUA.<\/p>\n<p>In a public health emergency, the manufacturing and approval of vaccines can be streamlined through emergency authorizations. Former Health Secretary Alex Azar declared a public health emergency on Jan. 31, 2020. The health emergency has been renewed several times, most recently in late April. The FDA allowed the use of the shots with just two months of safety data under an EUA. It\u2019s not the same as a Biologic License Application, or a request for full approval, which requires at least six months of data.<\/p>\n<p>\u201cThe way that works is the companies have to submit in this case for a vaccine, a Biologics License Application, and that goes through somewhat more review, obviously than an EUA would,\u201d acting FDA Commissioner Dr. Janet Woodcock said on SiriusXM on April 30. \u201cAnd there are more manufacturing controls that are standard that are looked at and so forth.\u201d<\/p>\n<p>Full approval will be beneficial to the companies for multiple reasons, former FDA commissioner Dr. Robert Califf told CNBC. For one, it will allow the companies\u2019 vaccines to stay on the market once the pandemic is over and the U.S. is no longer considered in an \u201cemergency,\u201d he said.<\/p>\n<p>It also sets the stage for the companies to begin marketing the shots directly to consumers, he said. Companies can\u2019t promote their products under an EUA, he said.<\/p>\n<p>\u201cThe vaccines will still have to be administered under the supervision of a professional who\u2019s qualified,\u201d added Califf, who was the agency\u2019s commissioner under the Obama administration beginning in early 2016. \u201cIt\u2019s not like they can send the vaccines to people\u2019s homes. However, they can advertise on TV and promote their products under the watchful eye of the FDA.\u201d<\/p>\n<p>U.S. approval can also have far-reaching impacts beyond the companies who submit the applications, FDA advisors and health policy experts told CNBC.<\/p>\n<p>It could encourage more businesses, universities and other organizations to start requiring people to get the shots, they said, an already controversial move that has impacted millions of students and employees across the U.S. It may also raise confidence in the vaccines and combat vaccine hesitancy, they said.<\/p>\n<p>\u00bb Subscribe to CNBC TV: https:\/\/cnb.cx\/SubscribeCNBCtelevision<br \/>\n\u00bb Subscribe to CNBC: https:\/\/cnb.cx\/SubscribeCNBC<br \/>\n\u00bb Subscribe to CNBC Classic: https:\/\/cnb.cx\/SubscribeCNBCclassic <\/p>\n<p>Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.<\/p>\n<p>The News with Shepard Smith is CNBC\u2019s daily news podcast providing deep, non-partisan coverage and perspective on the day\u2019s most important stories. Available to listen by 8:30pm ET \/ 5:30pm PT daily beginning September 30: https:\/\/www.cnbc.com\/2020\/09\/29\/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast <\/p>\n<p>Connect with CNBC News Online<br \/>\nGet the latest news: http:\/\/www.cnbc.com\/<br \/>\nFollow CNBC on LinkedIn: https:\/\/cnb.cx\/LinkedInCNBC<br \/>\nFollow CNBC News on Facebook: https:\/\/cnb.cx\/LikeCNBC<br \/>\nFollow CNBC News on Twitter: https:\/\/cnb.cx\/FollowCNBC<br \/>\nFollow CNBC News on Instagram: https:\/\/cnb.cx\/InstagramCNBC<\/p>\n<p>https:\/\/www.cnbc.com\/select\/best-credit-cards\/ <\/p>\n<p>#CNBC<br \/>\n#CNBCTV<br \/>\n\t\t\t\t\t\t\t\t\t<br \/><a href=\"https:\/\/www.youtube.com\/watch?v=2i3unvJEKWk\">source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Meg Tirrell joins &#8216;The News with Shepard Smith&#8217; to report how employers are making vaccines mandatory for employees. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https:\/\/cnb.cx\/2NGeIvi Pfizer and BioNTech have already started their application process for full U.S. approval of their Covid-19 vaccine. Rival Moderna is expected to submit [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-15396","post","type-post","status-publish","format-standard","hentry","category-get-financing-dental-practice"],"_links":{"self":[{"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/posts\/15396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/comments?post=15396"}],"version-history":[{"count":0,"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/posts\/15396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/media?parent=15396"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/categories?post=15396"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.edentalpracticefinancing.com\/blog\/wp-json\/wp\/v2\/tags?post=15396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}